Hologic Inc. (HOLX)

$75.1

+0.18

(+0.24%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Hologic Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 945.3M → 1.01B (in $), with an average increase of 6.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -40.5M → 246.5M (in $), with an average increase of 104.0% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 39.0% return, outperforming this stock by 48.2%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 38.1% return, outperforming this stock by 40.4%

Performance

  • $74.53
    $75.23
    $75.10
    downward going graph

    0.76%

    Downside

    Day's Volatility :0.92%

    Upside

    0.17%

    downward going graph
  • $64.02
    $87.88
    $75.10
    downward going graph

    14.75%

    Downside

    52 Weeks Volatility :27.15%

    Upside

    14.54%

    downward going graph

Returns

PeriodHologic Inc.Sector (Health Care)S&P500
3 Months
1.86%
-0.7%
5.0%
6 Months
10.32%
6.6%
16.4%
1 Year
-9.2%
3.7%
20.9%
3 Years
-2.3%
14.0%
20.0%

Highlights

Market Capitalization
17.6B
Book Value
$19.84
Earnings Per Share (EPS)
2.11
PE Ratio
35.6
PEG Ratio
1.45
Wall Street Target Price
86.07
Profit Margin
12.98%
Operating Margin TTM
22.38%
Return On Assets TTM
6.49%
Return On Equity TTM
10.57%
Revenue TTM
4.0B
Revenue Per Share TTM
16.23
Quarterly Revenue Growth YOY
-5.7%
Gross Profit TTM
2.5B
EBITDA
1.2B
Diluted Eps TTM
2.11
Quarterly Earnings Growth YOY
0.37
EPS Estimate Current Year
4.03
EPS Estimate Next Year
4.39
EPS Estimate Current Quarter
0.95
EPS Estimate Next Quarter
0.98

Analyst Recommendation

Buy
    56%Buy
    44%Hold
    0
    0%Sell
Based on 25 Wall street analysts offering stock ratings for Hologic Inc.(by analysts ranked 0 to 5 stars)
Based on 25 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
15
Hold
11
11
11
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 14.61%

Current $75.10
Target $86.07

Company Financials

FY18Y/Y Change
Revenue
3.2B
↑ 5.2%
Net Income
-111.3M
↓ 114.73%
Net Profit Margin
-3.46%
↓ 28.16%
FY19Y/Y Change
Revenue
3.4B
↑ 4.64%
Net Income
-40.2M
↓ 63.88%
Net Profit Margin
-1.19%
↑ 2.27%
FY20Y/Y Change
Revenue
3.8B
↑ 12.15%
Net Income
1.1B
↓ 2874.13%
Net Profit Margin
29.53%
↑ 30.72%
FY21Y/Y Change
Revenue
5.6B
↑ 49.14%
Net Income
1.9B
↑ 67.82%
Net Profit Margin
33.23%
↑ 3.7%
FY22Y/Y Change
Revenue
4.9B
↓ 13.66%
Net Income
1.3B
↓ 30.43%
Net Profit Margin
26.77%
↓ 6.46%
FY23Y/Y Change
Revenue
4.0B
↓ 17.12%
Net Income
456.0M
↓ 64.98%
Net Profit Margin
11.31%
↓ 15.46%
Q3 FY22Q/Q Change
Revenue
953.3M
↓ 4.93%
Net Income
118.7M
↓ 48.03%
Net Profit Margin
12.45%
↓ 10.33%
Q4 FY22Q/Q Change
Revenue
1.1B
↑ 12.68%
Net Income
187.4M
↑ 57.88%
Net Profit Margin
17.45%
↑ 5.0%
Q1 FY23Q/Q Change
Revenue
1.0B
↓ 4.44%
Net Income
218.5M
↑ 16.6%
Net Profit Margin
21.29%
↑ 3.84%
Q2 FY23Q/Q Change
Revenue
984.4M
↓ 4.1%
Net Income
-40.5M
↓ 118.54%
Net Profit Margin
-4.11%
↓ 25.4%
Q3 FY23Q/Q Change
Revenue
945.3M
↓ 3.97%
Net Income
90.6M
↓ 323.7%
Net Profit Margin
9.58%
↑ 13.69%
Q4 FY23Q/Q Change
Revenue
1.0B
↑ 7.17%
Net Income
246.5M
↑ 172.08%
Net Profit Margin
24.33%
↑ 14.75%
FY18Y/Y Change
Total Assets
7.2B
↓ 9.38%
Total Liabilities
4.8B
↓ 7.56%
FY19Y/Y Change
Total Assets
6.6B
↓ 8.57%
Total Liabilities
4.3B
↓ 9.79%
FY20Y/Y Change
Total Assets
7.2B
↑ 8.84%
Total Liabilities
4.5B
↑ 3.61%
FY21Y/Y Change
Total Assets
8.9B
↑ 23.96%
Total Liabilities
4.7B
↑ 4.74%
FY22Y/Y Change
Total Assets
9.1B
↑ 1.7%
Total Liabilities
4.2B
↓ 10.77%
FY23Y/Y Change
Total Assets
9.1B
↑ 0.75%
Total Liabilities
4.1B
↓ 1.73%
Q3 FY22Q/Q Change
Total Assets
9.1B
↓ 3.06%
Total Liabilities
4.2B
↓ 3.77%
Q4 FY22Q/Q Change
Total Assets
9.3B
↑ 2.42%
Total Liabilities
4.2B
↑ 0.07%
Q1 FY23Q/Q Change
Total Assets
9.4B
↑ 1.71%
Total Liabilities
4.1B
↓ 1.19%
Q2 FY23Q/Q Change
Total Assets
9.3B
↓ 1.17%
Total Liabilities
4.2B
↑ 0.19%
Q3 FY23Q/Q Change
Total Assets
9.1B
↓ 2.13%
Total Liabilities
4.1B
↓ 0.81%
Q4 FY23Q/Q Change
Total Assets
8.5B
↓ 7.33%
Total Liabilities
3.8B
↓ 7.44%
FY18Y/Y Change
Operating Cash Flow
732.9M
↑ 8730.12%
Investing Cash Flow
-195.2M
↓ 168.3%
Financing Cash Flow
-404.8M
↑ 30.92%
FY19Y/Y Change
Operating Cash Flow
649.5M
↓ 11.38%
Investing Cash Flow
-280.7M
↑ 43.8%
Financing Cash Flow
-431.5M
↑ 6.6%
FY20Y/Y Change
Operating Cash Flow
896.6M
↑ 38.04%
Investing Cash Flow
-141.6M
↓ 49.55%
Financing Cash Flow
-659.9M
↑ 52.93%
FY21Y/Y Change
Operating Cash Flow
2.3B
↑ 159.92%
Investing Cash Flow
-1.3B
↑ 838.98%
Financing Cash Flow
-529.8M
↓ 19.72%
FY22Y/Y Change
Operating Cash Flow
2.1B
↓ 8.78%
Investing Cash Flow
-206.3M
↓ 84.48%
Financing Cash Flow
-756.0M
↑ 42.7%
FY23Y/Y Change
Operating Cash Flow
1.1B
↓ 50.55%
Investing Cash Flow
-152.1M
↓ 26.27%
Financing Cash Flow
-483.2M
↓ 36.08%
Q3 FY22Q/Q Change
Operating Cash Flow
168.6M
↓ 49.02%
Investing Cash Flow
-32.1M
↑ 227.55%
Financing Cash Flow
-169.8M
↓ 29.31%
Q4 FY22Q/Q Change
Operating Cash Flow
253.4M
↑ 50.3%
Investing Cash Flow
-41.0M
↑ 27.73%
Financing Cash Flow
-113.5M
↓ 33.16%
Q1 FY23Q/Q Change
Operating Cash Flow
206.3M
↓ 18.59%
Investing Cash Flow
-16.4M
↓ 60.0%
Financing Cash Flow
-49.5M
↓ 56.39%
Q2 FY23Q/Q Change
Operating Cash Flow
332.8M
↑ 61.32%
Investing Cash Flow
-38.7M
↑ 135.98%
Financing Cash Flow
-109.6M
↑ 121.41%
Q3 FY23Q/Q Change
Operating Cash Flow
258.7M
↓ 22.27%
Investing Cash Flow
-56.0M
↑ 44.7%
Financing Cash Flow
-210.6M
↑ 92.15%

Technicals Summary

Sell

Neutral

Buy

Hologic Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Hologic Inc.
Hologic Inc.
-1.87%
10.32%
-9.2%
-2.3%
72.63%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-4.7%
35.81%
38.95%
38.38%
112.57%
Resmed Inc.
Resmed Inc.
-8.97%
22.05%
-22.01%
-15.48%
75.2%
Becton, Dickinson And Company
Becton, Dickinson And Company
-2.32%
-10.48%
-8.43%
-10.33%
1.9%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-4.64%
0.62%
4.23%
19.12%
238.38%
Alcon Ag
Alcon Ag
-6.1%
7.94%
11.1%
7.08%
42.78%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Hologic Inc.
Hologic Inc.
35.6
35.6
1.45
4.03
0.11
0.06
NA
19.84
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
75.26
75.26
7.13
6.25
0.15
0.08
NA
37.77
Resmed Inc.
Resmed Inc.
30.61
30.61
1.75
7.41
0.22
0.11
0.01
30.47
Becton, Dickinson And Company
Becton, Dickinson And Company
52.86
52.86
1.34
12.95
0.05
0.03
0.02
87.68
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
48.1
48.1
6.72
7.62
0.21
0.12
0.0
39.2
Alcon Ag
Alcon Ag
40.62
40.62
4.59
3.06
0.05
0.02
0.0
41.81
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Hologic Inc.
Hologic Inc.
Buy
$17.6B
72.63%
35.6
12.98%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$134.2B
112.57%
75.26
25.24%
Resmed Inc.
Resmed Inc.
Buy
$27.2B
75.2%
30.61
19.77%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.8B
1.9%
52.86
6.44%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$27.8B
238.38%
48.1
20.12%
Alcon Ag
Alcon Ag
Buy
$39.5B
42.78%
40.62
10.3%

Institutional Holdings

  • Vanguard Group Inc

    11.79%

  • BlackRock Inc

    10.34%

  • T. Rowe Price Investment Management,Inc.

    9.40%

  • State Street Corporation

    4.73%

  • Citadel Advisors Llc

    2.66%

  • Geode Capital Management, LLC

    2.38%

Company Information

driven by our ethos, the science of sure, we’re a diverse, dedicated, creative team that develops, markets and services some of the most innovative and accurate diagnostic imaging systems and surgical products on the planet. while we’re focused and passionate about our work, we never forget that what we’re really doing is giving people greater confidence and peace of mind in their diagnosis—enabling healthier lives, everywhere, every day. connect with us at hologic.com, on facebook at facebook.com/hologicjobs, and on twitter @hologic_jobs.

Organization
Hologic Inc.
Employees
6990
CEO
Mr. Stephen P. MacMillan
Industry
Health Technology

Discover More

FAQs